Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN
1997-6933
(print)
ISSN
2500-2139
(online)
Register
Login
Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Clinical Oncohematology
Basic Research and Clinical Practice
ИФ РИНЦ:
0,587
H-INDEX:
16
Home
About the Journal
Aims and Scope
Editorial Board
Peer Review
Publishing Ethics and Malpractice Statement
Indexing and Abstracting
Ownership, management and funding
Open Access Policy and Publication Fee
Articles
Current
Journal pre-proofs
Archive
SUPPLEMENT
Sections
LYMPHOID TUMORS
MYELOID TUMORS
BONE MARROW TRANSPLANTATION
ANEMIAS
AUTOIMMUNE DISEASES
CLINICAL TRIALS
NOVEL CORONAVIRUS INFECTION
NEWS
NEW TECHNOLOGIES
REVIEWS
COMPLICATIONS OF CHEMOTHERAPY
PRACTICAL RECOMMENDATIONS
RARE HEMATOLOGICAL TUMORS AND SYNDROMES
EXPERIMENTAL STUDIES
Submission
Search
Register
Login
Home
/
REVIEWS
REVIEWS
Diagnostic Value of Platelet Transcriptome in Myeloproliferative Neoplasms
I.A. Olkhovskiy, M.A. Stolyar, A.S. Gorbenko
131-141
01.04.2026
Autophagy: cell death or survival strategy?
O.V. Kovaleva, M.S. Shitova, I.B. Zborovskaya
103-113
01.07.2025
Functional Cure as a New Concept of Therapy for Multiple Myeloma
Sergei Vyacheslavovich Semochkin
105-120
01.04.2025
Chronic Lymphocytic Leukemia: A Genomic Landscape and Cellular Signal Pathways
M.A. Mikhaleva, Evgenii Olegovich Kunevich, A.Yu. Kuvshinov, S.V. Voloshin
21-37
01.01.2025
The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review
Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina
10-20
01.01.2025
Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review
Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis
404-414
01.10.2024
The Value of Combined PET/CT in Diffuse Large B-Cell Lymphoma: Historical Background, Evolution of Views, and Current Opportunities of the Method (Literature Review)
Artem Andreevich Vovchenko, N.A. Falaleeva, A.A. Danilenko, A.Yu. Terekhova, M.M. Khodzhibekova, A.M. Chelmakov, A.G. Zamotina, A.S. Dikova, S.V. Ruchkova, Yu.V. Sinitsyna, V.Yu. Kovalskaya, A.N. Perepelitsyna, A.N. Balashova, D.A. Manaenkov, S.A. Ivanov
66-75
17.05.2024
Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View
Sergei Vyacheslavovich Semochkin
94-108
01.04.2024
Plasmablastic Lymphoma and Plasmablastic Myeloma: А Diagnostic Dilemma (Literature Review)
Mariya Vladimirovna Melnikova, A.M. Kovrigina
129-140
01.04.2024
PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done
Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova
109-128
01.04.2024
Historical Background of the Role of Bone Marrow Core Biopsy in the Staging System for Classical Hodgkin Lymphoma and the Current View in the Era of PET-CT: A Literature Review
Anatolii Aleksandrovich Danilenko, N.A. Falaleeva, S.V. Shakhtarina
351-360
28.09.2023
The Role of Leukocytes in the Formation of Neutrophil Extracellular Traps and Thrombosis in Ph-Negative Myeloproliferative Neoplasms: A Literature Review
Boldukyz Tolgonbaevna Dzhumabaeva
263-267
09.06.2023
Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment
Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov
242-262
09.06.2023
Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
Sergei Vyacheslavovich Semochkin
229-241
09.06.2023
KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia
Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev
119-127
03.03.2023
Morpho-Immunohistochemical Characteristics of Different Mycosis Fungoides Stages: A Literature Review
Andrei Alekseevich Sherstnev, A.M. Kovrigina
109-118
03.03.2023
Combination of Ibrutinib and Venetoclax in the Therapy of Chronic Lymphocytic Leukemia: A Review of the Latest Data from Clinical Studies
A.A. Petrenko, Mariya Igorevna Kislova, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin
37-45
01.01.2023
Prognostic Models in Medicine
Aleksander Sergeevich Luchinin
27-36
01.01.2023
Chronic Hepatitis С and Oncohematological Diseases
Tamara Vasilevna Antonova, M.S. Nozhkin, D.A. Lioznov
46-53
01.01.2023
Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review
Anatolii Aleksandrovich Danilenko, S.V. Shakhtarina, N.A. Falaleeva
414-423
01.10.2022
1-20 of 83
Next
oa-antiplagiat
Make a Submission
Make a Submission
Banner ROHS
Indexing Databases
Editor-in-Chief
Gayane Sepugovna Tumyan
ARCHIVE
2026
Issue 1 (2026)
2025
Issue 1 (2025)
Issue 2 (2025)
Issue 3 (2025)
Issue 4 (2025)
2024
Issue 1 (2024)
Issue 2 (2024)
Issue 3 (2024)
Issue 4 (2024)
2023
Issue 1 (2023)
Issue 2 (2023)
Issue 3 (2023)
Issue 4 (2023)
2022
Issue 1 (2022)
Issue 2 (2022)
Issue 3 (2022)
Issue 4 (2022)
2021
Issue 1 (2021)
Issue 2 (2021)
Issue 3 (2021)
Issue 4 (2021)
2020
Issue 1 (2020)
Issue 2 (2020)
Issue 3 (2020)
Issue 4 (2020)
2019
Issue 1 (2019)
Issue 2 (2019)
Issue 3 (2019)
Issue 4 (2019)
2018
Issue 1 (2018)
Issue 2 (2018)
Issue 3 (2018)
Issue 4 (2018)
2017
Issue 1 (2017)
Issue 2 (2017)
Issue 3 (2017)
Issue 4 (2017)
2016
Issue 1 (2016)
Issue 2 (2016)
Issue 3 (2016)
Issue 4 (2016)
2015
Issue 1 (2015)
Issue 2 (2015)
Issue 3 (2015)
Issue 4 (2015)
2014
Issue 1 (2014)
Issue 2 (2014)
Issue 3 (2014)
Issue 4 (2014)
2013
Issue 1 (2013)
Issue 2 (2013)
Issue 3 (2013)
Issue 4 (2013)
ALL ARCHIVE
Keywords
Most Read Articles
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
3564
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
1762
Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
1229
Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
1129
Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
1021
Up